Durect Corp (DRRX)

HEALTH CARE: BIOTECHNOLOGY & LIFE SCIENCES
SIC: PHARMACEUTICAL PREPARATIONS

10260 BUBB RD CUPERTINO, CA 95014

Develops pharmaceutical systems based on proprietary drug delivery technology platforms: the SABER Delivery System, the TRANSDUR Delivery System, the ORADUR sustained release oral gel-cap technology, the DURIN Biodegradable Implant, the DUROS System, and MICRODUR Biodegradable Microparticulates.

Data based on most recent fiscal year report
Market Cap405.88 Million Shares Outstanding192.36 Million Avg Volume1.237 Million
1-Yr BETA vs S&P TR0.745 Current Ratio5.45 Quick Ratio5.0
View SEC Filings from DRRX instead.

View recent insider trading info

Funds Holding DRRX (via 13F filings)

Refresh Download CSV Download Excel (.xlsx) Download TSV
Filter by:
to
to
to
Refresh
*Shares are split adjusted
*Please note that if a filer hasn't submitted a 13F filing for a quarter then the filer's shares will be listed as "Sold All"

Mutual Funds Holding DRRX BETA

Active Schedule 13D and 13G filings

Please sign in first

Open Market Buys/Sells Last 60 Days

Open Market Buys (P)

227.5 Thousand total shares from 3 transactions

Open Market Sells (S)

none

Exercise Derivative Conversion (M)

none

Current/Former Insiders

Insider Name Type Last Reported Shares Held Last Reported Date Filings in past year

BLEICHROEDER LP

  • 10% Owner
2,089,488 2020-02-20 2

BROWN JAMES E PRESIDENT & CEO

  • Officer
  • Director
0 2020-01-21 1

JOICE JUDY R SR. VP OPERATIONS & CORP QA

  • Officer
0 2020-01-21 1

ARENBERG MICHAEL CHIEF FINANCIAL OFFICER

  • Officer
0 2020-01-21 2

SHEPARD JAY

  • Director
0 2020-01-15 0

LIU JEAN I GC/EVP, LEG AFAIRS

  • Officer
71,385 2019-12-19 0

CASEY MICHAEL D

0 2019-11-20 0

SAXE JON S

0 2019-10-21 7

FIRST EAGLE INVESTMENT MANAGEMENT, LLC

FIRST EAGLE HOLDINGS, INC.

  • 10% Owner
0 2019-09-01 1

FARFEL GAIL M EVP/CHIEF DEVELOPMENT OFFICER

  • Officer
4,891 2019-08-22 2

FIRST EAGLE INVESTMENT MANAGEMENT, LLC

21 APRIL FUND, L.P.

21 APRIL FUND, LTD.

FIRST EAGLE VALUE IN BIOTECHNOLOGY MASTER FUND, LTD.

FIRST EAGLE HOLDINGS, INC.

  • 10% Owner
26,476,546 2019-06-20 1

HOFFMANN DAVE

  • Director
0 2019-06-19 1

NEUKERMANS ARMAND

  • Director
0 2019-06-19 1

BLASCHKE TERRENCE F

  • Director
0 2019-06-19 1

BENITO SIMON X

  • Director
0 2019-06-19 1

ROBERTSON JUDITH J.

  • Director
0 2019-04-23 2

STAUFFER JOSEPH WILLIAM CHIEF MEDICAL OFFICER

  • Officer
2,000 2018-10-17 0

THEEUWES FELIX CHAIRMAN AND CSO

  • Officer
  • Director
0 2018-01-26 0

HOGAN MATTHEW J CHIEF FINANCIAL OFFICER

  • Officer
0 2018-01-26 0

21 APRIL FUND, LTD.

21 APRIL FUND, L.P.

FIRST EAGLE VALUE IN BIOTECHNOLOGY MASTER FUND, LTD.

FIRST EAGLE HOLDINGS, INC.

  • 10% Owner
22,381,546 2016-09-26 0

YUM SU IL EXEC. VP PHARM./R&D

  • Officer
0 2015-01-09 0

LANGECKER PETER CHIEF EXECUTIVE OFFICER

  • Officer
  • Director
77,993 2013-08-08 0

MENDENHALL PAULA V EXEC. VP OF OPERATIONS/ADMIN.

  • Officer
0 2012-02-03 0

Insider Transactions Last 60 Days

Reporting Owners Transaction Date Transaction Code Shares Share Price Acquired or Disposed Shares Owned Following Transaction Combined shares owned after filing Direct/Indirect Ownership 10b-5

BLEICHROEDER LP - > 10% Owner see footnote

2020-02-06 P 75,000 $1.65 a 26,704,044 26,704,044.00 indirect

BLEICHROEDER LP - > 10% Owner see footnote

2020-02-05 P 74,998 $1.69 a 26,629,044 26,704,044.00 indirect

BLEICHROEDER LP - > 10% Owner see footnote

2020-02-04 P 77,500 $1.70 a 26,554,046 26,704,044.00 indirect

BROWN JAMES E - Director - Officer PRESIDENT & CEO

2020-01-21 A 86,855 a 86,855 0.00 direct

ARENBERG MICHAEL - Officer CHIEF FINANCIAL OFFICER

2020-01-21 A 23,236 a 23,236 0.00 direct

JOICE JUDY R - Officer SR. VP OPERATIONS & CORP QA

2020-01-21 A 82,278 a 82,278 0.00 direct

ARENBERG MICHAEL - Officer CHIEF FINANCIAL OFFICER

2020-01-21 A 101,764 a 101,764 0.00 direct

BROWN JAMES E - Director - Officer PRESIDENT & CEO

2020-01-21 A 138,145 a 138,145 0.00 direct

JOICE JUDY R - Officer SR. VP OPERATIONS & CORP QA

2020-01-21 A 2,722 a 2,722 0.00 direct

Elevate your investments